(Source: In August 2025 , Viking Therapeutic announced encouraging mid-stage trial results for its experimental oral/injectable weight loss drug VK2735, which achieved up to 12.2% body weight reduction over 12 weeks, through shares dropped due to higher treatment discontinuation from gastrointestinal side effects
Some patients report feeling queasy for a few hours after taking the medication, which can sometimes interfere with daily activities
The original Mass Eye and Ear study found even more dramatic risk elevations
GLP-1s arent included in Nices covered medications, and can cost over $1,000/month without insurance
doi:10.1677/JOE-10-0004 199
Pricing analysis and what bulk retatrutide actually costs from China Pricing transparency is one of the most requested pieces of information from researchers considering Chinese sourcing, and one of the hardest to pin down because prices fluctuate with raw material costs, order volume, supplier relationships, and market demand